ID   3BHS7_HUMAN             Reviewed;         369 AA.
AC   Q9H2F3; Q96M28; Q9BSN9;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2004, sequence version 2.
DT   10-MAY-2017, entry version 139.
DE   RecName: Full=3 beta-hydroxysteroid dehydrogenase type 7;
DE   AltName: Full=3 beta-hydroxysteroid dehydrogenase type VII;
DE            Short=3-beta-HSD VII;
DE   AltName: Full=3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase;
DE            Short=C(27) 3-beta-HSD;
DE            EC=1.1.1.-;
DE   AltName: Full=Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase;
DE            EC=1.1.1.181;
GN   Name=HSD3B7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INVOLVEMENT IN
RP   CBAS1, AND VARIANT ALA-250.
RX   PubMed=11067870; DOI=10.1172/JCI10902;
RA   Schwarz M., Wright A.C., Davis D.L., Nazer H., Bjorkhem I.,
RA   Russell D.W.;
RT   "The bile acid synthetic gene 3beta-hydroxy-delta(5)-C(27)-steroid
RT   oxidoreductase is mutated in progressive intrahepatic cholestasis.";
RL   J. Clin. Invest. 106:1175-1184(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Stomach, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANTS CBAS1 SER-19 AND LYS-147, AND CHARACTERIZATION OF VARIANT
RP   CBAS1 LYS-147.
RX   PubMed=12679481; DOI=10.1210/jc.2002-021580;
RA   Cheng J.B., Jacquemin E., Gerhardt M., Nazer H., Cresteil D.,
RA   Heubi J.E., Setchell K.D., Russell D.W.;
RT   "Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase
RT   deficiency in 16 patients with loss of bile acid synthesis and liver
RT   disease.";
RL   J. Clin. Endocrinol. Metab. 88:1833-1841(2003).
CC   -!- FUNCTION: The 3-beta-HSD enzymatic system plays a crucial role in
CC       the biosynthesis of all classes of hormonal steroids. HSD VII is
CC       active against four 7-alpha-hydroxylated sterols. Does not
CC       metabolize several different C(19/21) steroids as substrates.
CC       Involved in bile acid synthesis (PubMed:11067870). Plays a key
CC       role in cell positioning and movement in lymphoid tissues by
CC       mediating degradation of 7-alpha,25-dihydroxycholesterol (7-
CC       alpha,25-OHC): 7-alpha,25-OHC acts as a ligand for the G protein-
CC       coupled receptor GPR183/EBI2, a chemotactic receptor for a number
CC       of lymphoid cells. {ECO:0000250|UniProtKB:Q9EQC1,
CC       ECO:0000269|PubMed:11067870}.
CC   -!- CATALYTIC ACTIVITY: 3-beta-hydroxy-Delta(5)-steroid + NAD(+) = 3-
CC       oxo-Delta(5)-steroid + NADH.
CC   -!- CATALYTIC ACTIVITY: Cholest-5-ene-3-beta,7-alpha-diol + NAD(+) =
CC       7-alpha-hydroxycholest-4-en-3-one + NADH.
CC   -!- PATHWAY: Lipid metabolism; steroid biosynthesis.
CC   -!- INTERACTION:
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-3918847, EBI-10172290;
CC       P60410:KRTAP10-8; NbExp=5; IntAct=EBI-3918847, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-3918847, EBI-10172052;
CC       Q9BYR5:KRTAP4-2; NbExp=3; IntAct=EBI-3918847, EBI-10172511;
CC       Q7Z3S9:NOTCH2NL; NbExp=3; IntAct=EBI-3918847, EBI-945833;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-3918847, EBI-742487;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H2F3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H2F3-2; Sequence=VSP_042658;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Congenital bile acid synthesis defect 1 (CBAS1)
CC       [MIM:607765]: A primary defect in bile synthesis leading to
CC       progressive liver disease. Clinical features include neonatal
CC       jaundice, severe intrahepatic cholestasis, cirrhosis.
CC       {ECO:0000269|PubMed:11067870, ECO:0000269|PubMed:12679481}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the 3-beta-HSD family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF277719; AAG37824.1; -; mRNA.
DR   EMBL; AK057436; BAB71486.1; -; mRNA.
DR   EMBL; AK290950; BAF83639.1; -; mRNA.
DR   EMBL; AK292068; BAF84757.1; -; mRNA.
DR   EMBL; AC135048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471192; EAW52183.1; -; Genomic_DNA.
DR   EMBL; BC004929; AAH04929.1; -; mRNA.
DR   CCDS; CCDS10698.1; -. [Q9H2F3-1]
DR   CCDS; CCDS45466.1; -. [Q9H2F3-2]
DR   RefSeq; NP_001136249.1; NM_001142777.1. [Q9H2F3-2]
DR   RefSeq; NP_001136250.1; NM_001142778.1. [Q9H2F3-2]
DR   RefSeq; NP_079469.2; NM_025193.3. [Q9H2F3-1]
DR   RefSeq; XP_005255658.2; XM_005255601.3. [Q9H2F3-1]
DR   RefSeq; XP_011544262.1; XM_011545960.2. [Q9H2F3-1]
DR   RefSeq; XP_011544263.1; XM_011545961.1. [Q9H2F3-1]
DR   RefSeq; XP_011544264.1; XM_011545962.2. [Q9H2F3-2]
DR   RefSeq; XP_016879221.1; XM_017023732.1. [Q9H2F3-2]
DR   UniGene; Hs.460618; -.
DR   ProteinModelPortal; Q9H2F3; -.
DR   SMR; Q9H2F3; -.
DR   BioGrid; 123208; 14.
DR   IntAct; Q9H2F3; 39.
DR   STRING; 9606.ENSP00000297679; -.
DR   SwissLipids; SLP:000001321; -.
DR   iPTMnet; Q9H2F3; -.
DR   PhosphoSitePlus; Q9H2F3; -.
DR   BioMuta; HSD3B7; -.
DR   DMDM; 47605550; -.
DR   EPD; Q9H2F3; -.
DR   MaxQB; Q9H2F3; -.
DR   PaxDb; Q9H2F3; -.
DR   PeptideAtlas; Q9H2F3; -.
DR   PRIDE; Q9H2F3; -.
DR   DNASU; 80270; -.
DR   Ensembl; ENST00000262520; ENSP00000262520; ENSG00000099377. [Q9H2F3-2]
DR   Ensembl; ENST00000297679; ENSP00000297679; ENSG00000099377. [Q9H2F3-1]
DR   GeneID; 80270; -.
DR   KEGG; hsa:80270; -.
DR   UCSC; uc002eaf.3; human. [Q9H2F3-1]
DR   CTD; 80270; -.
DR   DisGeNET; 80270; -.
DR   GeneCards; HSD3B7; -.
DR   H-InvDB; HIX0038797; -.
DR   HGNC; HGNC:18324; HSD3B7.
DR   HPA; HPA050521; -.
DR   HPA; HPA060847; -.
DR   MalaCards; HSD3B7; -.
DR   MIM; 607764; gene.
DR   MIM; 607765; phenotype.
DR   neXtProt; NX_Q9H2F3; -.
DR   OpenTargets; ENSG00000099377; -.
DR   Orphanet; 79301; Congenital bile acid synthesis defect type 1.
DR   PharmGKB; PA134940289; -.
DR   eggNOG; KOG1430; Eukaryota.
DR   eggNOG; COG0451; LUCA.
DR   GeneTree; ENSGT00550000074557; -.
DR   HOGENOM; HOG000167989; -.
DR   HOVERGEN; HBG000014; -.
DR   InParanoid; Q9H2F3; -.
DR   KO; K12408; -.
DR   OMA; NGRKVHG; -.
DR   OrthoDB; EOG091G09QZ; -.
DR   PhylomeDB; Q9H2F3; -.
DR   TreeFam; TF354279; -.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-HSA-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   UniPathway; UPA00062; -.
DR   GenomeRNAi; 80270; -.
DR   PRO; PR:Q9H2F3; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000099377; -.
DR   CleanEx; HS_HSD3B7; -.
DR   ExpressionAtlas; Q9H2F3; baseline and differential.
DR   Genevisible; Q9H2F3; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; TAS:Reactome.
DR   GO; GO:0047016; F:cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0035754; P:B cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:UniProtKB.
DR   InterPro; IPR002225; 3Beta_OHSteriod_DH/Estase.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF01073; 3Beta_HSD; 1.
DR   SUPFAM; SSF51735; SSF51735; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Intrahepatic cholestasis; Membrane; NAD;
KW   Oxidoreductase; Polymorphism; Reference proteome; Steroidogenesis;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    369       3 beta-hydroxysteroid dehydrogenase type
FT                                7.
FT                                /FTId=PRO_0000087791.
FT   TRANSMEM    289    309       Helical. {ECO:0000255}.
FT   TRANSMEM    311    331       Helical. {ECO:0000255}.
FT   ACT_SITE    159    159       Proton acceptor. {ECO:0000250}.
FT   BINDING     163    163       NAD. {ECO:0000250}.
FT   VAR_SEQ     178    369       VRGGLPLVTCALRPTGIYGEGHQIMRDFYRQGLRLGGWLFR
FT                                AIPASVEHGRVYVGNVAWMHVLAARELEQRATLMGGQVYFC
FT                                YDGSPYRSYEDFNMEFLGPCGLRLVGARPLLPYWLLVFLAA
FT                                LNALLQWLLRPLVLYAPLLNPYTLAVANTTFTVSTDKAQRH
FT                                FGYEPLFSWEDSRTRTILWVQAATGSAQ -> AMLPGCTCW
FT                                QPGSWSSGQP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042658.
FT   VARIANT      19     19       G -> S (in CBAS1).
FT                                {ECO:0000269|PubMed:12679481}.
FT                                /FTId=VAR_054775.
FT   VARIANT     147    147       E -> K (in CBAS1; loss of activity;
FT                                dbSNP:rs104894518).
FT                                {ECO:0000269|PubMed:12679481}.
FT                                /FTId=VAR_054776.
FT   VARIANT     250    250       T -> A (in dbSNP:rs9938550).
FT                                {ECO:0000269|PubMed:11067870}.
FT                                /FTId=VAR_031040.
FT   VARIANT     347    347       L -> P (in dbSNP:rs34212827).
FT                                /FTId=VAR_048100.
FT   CONFLICT    265    265       Y -> H (in Ref. 1; AAG37824).
FT                                {ECO:0000305}.
FT   CONFLICT    329    329       T -> A (in Ref. 1; AAG37824).
FT                                {ECO:0000305}.
SQ   SEQUENCE   369 AA;  41016 MW;  7254A5DAAFAC23E7 CRC64;
     MADSAQAQKL VYLVTGGCGF LGEHVVRMLL QREPRLGELR VFDQHLGPWL EELKTGPVRV
     TAIQGDVTQA HEVAAAVAGA HVVIHTAGLV DVFGRASPKT IHEVNVQGTR NVIEACVQTG
     TRFLVYTSSM EVVGPNTKGH PFYRGNEDTP YEAVHRHPYP CSKALAEWLV LEANGRKVRG
     GLPLVTCALR PTGIYGEGHQ IMRDFYRQGL RLGGWLFRAI PASVEHGRVY VGNVAWMHVL
     AARELEQRAT LMGGQVYFCY DGSPYRSYED FNMEFLGPCG LRLVGARPLL PYWLLVFLAA
     LNALLQWLLR PLVLYAPLLN PYTLAVANTT FTVSTDKAQR HFGYEPLFSW EDSRTRTILW
     VQAATGSAQ
//
